Table 1.
Study (location) | Age of trial participants in years | Duration of follow-up | Infections assessed | No of subjects in placebo group | No of subjects in treatment group | Jadad score | Comments |
---|---|---|---|---|---|---|---|
Chavance et al 1993 (France)21 | 60+ | 4 months | Respiratory, nose, throat, ear, skin, mouth, urinary, and gynaecological infections | 108 (of which 7 were lost to follow-up, leaving an effective sample size of 101) | 110 (of which 7 were lost to follow-up, leaving an effective sample size of 103) | 3 | Double blind |
Girodon et al 1999 (France)22 | 65+ | 2 years (maximum) | Respiratory and symptomatic urogenital infections | 182 (of which 4 withdrew and 51 died during the study, but all were included in analysis) | 181 (of which 3 withdrew and 55 died during the study, but all were included in analysis) | 4 | A double blind, 2×2 factorial trial (arms multivitamin only and minerals only excluded from meta-analyses) Population was from nursing homes |
Chandra 1992 (United States)23 | 65+ | 12 months | Any infection (diagnosis was based on clinical features and laboratory tests included blood count, radiography of the chest and sinuses, bacterial and fungal cultures of sputum, urine and blood, C reactive protein, and erythrocyte sedimentation rate) | 48 | 48 | 4 | Double blind |
Barringer et al 2003 (United States)24 | 65+ | 12 months | Upper respiratory tract infection, lower respiratory tract infection, influenza-like syndrome, gastrointestinal infection, and urinary tract infection | 17 | 18 65 (2 dropped out and were lost to follow-up leaving an effective sample size of 16) | 4 | People aged <65 years were excluded from the analysis. A large proportion of subjects had diabetes. Double blind |
Graat et al 2002, (Netherlands)25 | 60+ | 15 months (maximum) | Acute respiratory tract infections | 230 | 240 | 3 | A double blind, 2×2 factorial trial. Arms of vitamin E only and multivitamin+mineral + vitamin E have been excluded from meta-analyses |
Chandra 2002 (location not specified)26 | 50-65 | 12 months | Common adult infection illnesses diagnosed by fever, cough, elevated erythrocyte sedimentation rate and C reactive protein, x ray of the sinuses and chest, blood culture, sputum culture, and urine culture | 22 (three lost to follow-up, leaving an effective sample size of 19) | 22 | 4 | Double blind |
Jain 2002 (India)27 | 51-78 | 12 months | Respiratory infections | 18 | 18 | 2 | Blinding unclear |
Girodon et al 1997 (France)28 | 65+ | 2 years | Respiratory and symptomatic urogenital infections | 20 (of which 7 dropped out before end but were included in analysis) | 21 (of which 7 dropped out before end but were included in analysis) | 4 | A double blind, 2×2 factorial trial (arms multivitamin only and minerals only excluded from meta-analysis) Population was from nursing homes |